Volume 138, Issue 4, Pages (April 2010)

Slides:



Advertisements
Similar presentations
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Advertisements

Nogo-p4 Suppresses TrkA Signaling Induced by Low Concentrations of Nerve Growth Factor Through NgR1 in Differentiated PC12 Cells Neurosignals 2016;24:25-39.
Connective Tissue Growth Factor (CCN2) in Rat Pancreatic Stellate Cell Function: Integrin α5β1 as a Novel CCN2 Receptor  Runping Gao, David R. Brigstock 
Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure  Laurie L. Baggio, Qingling Huang, Theodore.
Volume 86, Issue 6, Pages (December 2014)
Volume 144, Issue 5, Pages e10 (May 2013)
Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 129, Issue 2, Pages (August 2005)
Volume 132, Issue 3, Pages (March 2007)
Cdc42 Inhibits ERK-Mediated Collagenase-1 (MMP-1) Expression in Collagen-Activated Human Keratinocytes  Maryam G. Rohani, Brian K. Pilcher, Peter Chen,
Volume 133, Issue 1, Pages (July 2007)
Volume 131, Issue 2, Pages (August 2006)
Volume 142, Issue 4, Pages (April 2012)
Volume 132, Issue 3, Pages (March 2007)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 138, Issue 7, Pages e1 (June 2010)
Volume 138, Issue 5, Pages e1 (May 2010)
Volume 138, Issue 5, Pages e4 (May 2010)
Volume 20, Issue 4, Pages (April 1998)
NF-κBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1β-induced and TNF-α-induced chondrocytes  Dr C. Lianxu, Ph.D.,
Volume 133, Issue 6, Pages (December 2007)
Volume 120, Issue 1, Pages (January 2001)
Substance P Enhances the Production of Interferon-induced Protein of 10 kDa by Human Keratinocytes in Synergy with Interferon-γ  Naoko Kanda, Shinichi.
Nod2-Induced Autocrine Interleukin-1 Alters Signaling by ERK and p38 to Differentially Regulate Secretion of Inflammatory Cytokines  Matija Hedl, Clara.
Volume 123, Issue 4, Pages (October 2002)
Volume 18, Issue 5, Pages (May 2010)
Volume 16, Issue 4, Pages (October 2009)
Volume 139, Issue 1, Pages (July 2010)
Volume 135, Issue 5, Pages e3 (November 2008)
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Liang Yang, Yong Qi, Yunlei Yang  Cell Reports 
Kupffer Cells Mediate Leptin-Induced Liver Fibrosis
Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Volume 122, Issue 4, Pages (April 2002)
Volume 56, Issue 3, Pages (September 1999)
Volume 116, Issue 1, Pages (January 1999)
P21-Activated Kinase 4 Critically Regulates Melanogenesis via Activation of the CREB/MITF and β-Catenin/MITF Pathways  Cheong-Yong Yun, Soon-Tae You,
Volume 127, Issue 1, Pages (July 2004)
Tomoyasu Hattori, Lukasz Stawski, Sashidhar S
Volume 132, Issue 4, Pages (April 2007)
Volume 136, Issue 4, Pages (April 2009)
Volume 138, Issue 5, Pages e1 (May 2010)
Volume 129, Issue 5, Pages (November 2005)
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
Volume 133, Issue 4, Pages (October 2007)
Microtubule-Targeted Drugs Inhibit VEGF Receptor-2 Expression by both Transcriptional and Post-Transcriptional Mechanisms  Markus Meissner, Andreas Pinter,
Volume 132, Issue 5, Pages (May 2007)
Volume 140, Issue 4, Pages (April 2011)
Volume 140, Issue 2, Pages (February 2011)
Volume 137, Issue 5, Pages (November 2009)
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Halofuginone, an Inhibitor of Type-I Collagen Synthesis and Skin Sclerosis, Blocks Transforming-Growth-Factor-β-Mediated Smad3 Activation in Fibroblasts 
Connective Tissue Growth Factor (CCN2) in Rat Pancreatic Stellate Cell Function: Integrin α5β1 as a Novel CCN2 Receptor  Runping Gao, David R. Brigstock 
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Volume 133, Issue 4, Pages (October 2007)
Volume 61, Issue 6, Pages (June 2002)
Regulation of the Melanoma Cell Adhesion Molecule Gene in Melanoma: Modulation of mRNA Synthesis by Cyclic Adenosine Monophosphate, Phorbol Ester, and.
Volume 134, Issue 1, Pages (January 2008)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Antimüllerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human.
Volume 124, Issue 1, Pages (January 2003)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Transient Receptor Potential Vanilloid-1 Mediates Heat-Shock-Induced Matrix Metalloproteinase-1 Expression in Human Epidermal Keratinocytes  Wen H. Li,
Nan-Lin Wu, Te-An Lee, Te-Lung Tsai, Wan-Wan Lin 
Volume 72, Issue 2, Pages (July 2007)
P21-Activated Kinase 4 Critically Regulates Melanogenesis via Activation of the CREB/MITF and β-Catenin/MITF Pathways  Cheong-Yong Yun, Soon-Tae You,
Presentation transcript:

Volume 138, Issue 4, Pages 1479-1490 (April 2010) Cocaine- and Amphetamine-Regulated Transcript Mediates the Actions of Cholecystokinin on Rat Vagal Afferent Neurons  Guillaume De Lartigue, Rod Dimaline, Andrea Varro, Helen Raybould, Claire Barbier De La Serre, Graham J. Dockray  Gastroenterology  Volume 138, Issue 4, Pages 1479-1490 (April 2010) DOI: 10.1053/j.gastro.2009.10.034 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Increased cocaine- and amphetamine-regulated transcript peptide (CARTp) secretion in vagal afferent neurons stimulated with cholecystokinin (CCK)8s. In cultured vagal afferent neurons treated with CCK8s (10 nM, 2 hours) there was increased CARTp secretion that was enhanced by leptin (10 ng/mL) and inhibited by ghrelin (10 nM). Mean ± standard error, n = 3 independent experiments; *P < .001. Gastroenterology 2010 138, 1479-1490DOI: (10.1053/j.gastro.2009.10.034) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Cocaine- and amphetamine-regulated transcript peptide (CARTp) increases receptor type 2 for neuropeptide Y and peptide-tyrosine-tyrosine (Y2R)- and CARTp- immunoreactivity in vagal afferent neurons in fasted rats, but has no effect on cannabinoid-1 receptor (CB1R), melanin-concentrating hormone receptor 1 (MCH1R), and melanin concentrating hormone (MCH) abundance. (A) CB1R immunoreactivity is detected in vagal afferent neurons of rats fasted for 24 hours and is decreased by cholecystokinin (CCK)8s (10 nmol, intraperitoneal [IP], 1 hours), but not by CARTp (2 nmol, IP, 1 hour). (B) Similar data for MCH and (C) for MCH1R expression. (D) Expression of Y2R is barely detectable in nodose neurons of rats fasted 24 hours, but is increased by CCK8s (10 nmol, IP, 1 hour) and by CARTp (2 nmol, IP, 1 hour); (E) similar data for CARTp expression. Representative results from 4–5 rats in each group. Scale bar = 30 μm. Gastroenterology 2010 138, 1479-1490DOI: (10.1053/j.gastro.2009.10.034) Copyright © 2010 AGA Institute Terms and Conditions

Figure 3 Cocaine- and amphetamine-regulated transcript peptide (CARTp) stimulates expression of receptor type 2 for neuropeptide Y and peptide-tyrosine-tyrosine (Y2R) and CARTp, but has no effect on cannabinoid-1 receptor (CB1R) and melanin-concentrating hormone (MCH) in cultured vagal afferent neurons. (A) Y2R immunoreactivity and corresponding 4′,6-diamidino-2-phenylindole (DAPI) staining in neurons (arrow) in serum-free medium (2 hours; control), or treated with 10 nM CCK8s (2 hours) or CARTp (2 nM) in serum-free medium. (B) Quantification of neurons exhibiting Y2R immunoreactivity after treatment with cholecystokinin (CCK)8s, phorbol 12-myristate-13-acetate (PMA) (100 nM) or CARTp based on visual identification of positively stained neurons in counts of at least 1000 cells in each independent experiment. (C) Data similar to panel B for CARTp-immunoreactive neurons. (D) MCH immunoreactivity and corresponding DAPI staining in neurons in serum-free medium (2 hours control), or treated with CCK8s (10 nM) or CARTp (2 nM) in serum-free media. (E) Quantification of neurons exhibiting MCH immunoreactivity after treatment with CCK8s, PMA (100 nM) or CARTp. (F) Similar data to panel E for CB1R-immunoreactive neurons. Scale bar = 50 μm. Mean ± standard error, n = 6 independent experiments; **P < .01; ***P < .001. Gastroenterology 2010 138, 1479-1490DOI: (10.1053/j.gastro.2009.10.034) Copyright © 2010 AGA Institute Terms and Conditions

Figure 4 Cocaine- and amphetamine-regulated transcript peptide (CARTp) stimulation of CART-luciferase (Luc) and receptor type 2 for neuropeptide Y and peptide-tyrosine-tyrosine (Y2R)-Luc in vagal afferent neurons: potentiation by leptin and inhibition by ghrelin. (A) Graded concentrations of CARTp stimulated expression of 3.45 kb CART-Luc, and in the presence of leptin (10 ng/mL) the curve was moved to the left. (B) Pre-incubation (30 minutes) with 10 nM ghrelin inhibited CART-Luc responses to 2 nM CARTp. (C) Graded concentrations of CARTp stimulated expression of 3.034 kb Y2R-Luc and leptin (10 ng/mL) moved the curve to the left. (D) Pre-incubation (30 minutes) with 10 nM ghrelin inhibited Y2R-Luc responses to 2 nM CARTp. (E) CCK8s (10 nM) inhibited expression of 1.6 kb of melanin concentrating hormone (MCH)-Luc promoter-reporter construct, and this was reversed by ghrelin (10 nM), but CARTp (2 nM) had no effect. Mean ± standard error, n = 3 independent experiments; *P < .05, **P < .01, ***P < .001. Gastroenterology 2010 138, 1479-1490DOI: (10.1053/j.gastro.2009.10.034) Copyright © 2010 AGA Institute Terms and Conditions

Figure 5 Cocaine- and amphetamine-regulated transcript peptide (CARTp) mediates excitatory effects of cholecystokinin (CCK) on cultured vagal afferent neurons. (A) CCK8s (10 nM, 2 hours) stimulated expression of 3.45 kb CART-luciferase (Luc); co-transfection with CART small interfering RNA (siRNA) (50 nM), but not a scrambled sequence, reduced the number of CART positive cells by 36% ± 3.9% (P < .05) and reduced fluorescence intensity in most of the remainder, and significantly inhibited the response. (B) Similarly, CCK8s (10 nM, 2 hours) stimulated expression of 3.034 kb receptor type 2 for neuropeptide Y and peptide-tyrosine-tyrosine (Y2R)-Luc and co-transfection with CART siRNA inhibited this. But, (C) CCK8s (10 nM, 2 hours) inhibited expression of 1.6 kb melanin concentrating hormone (MCH)-Luc and CART siRNA had no effect on the response. (D) Pretreatment of cells with brefeldin A (BFA, 10 μg/mL) inhibited the CART-Luc and, (E) the Y2R-Luc responses to CCK8s, respectively. **P < .01, ***P < .001. Gastroenterology 2010 138, 1479-1490DOI: (10.1053/j.gastro.2009.10.034) Copyright © 2010 AGA Institute Terms and Conditions

Figure 6 Cocaine- and amphetamine-regulated transcript peptide (CARTp) activates cyclic 3′,5′ adenosine monophosphate response element binding protein (CREB) and early growth response protein-1 (EGR1) to stimulate CART and receptor type 2 for neuropeptide Y and peptide-tyrosine-tyrosine (Y2R) expression. (A) Strong nuclear staining of phosphoCREB in vagal afferent neurons (arrows) transferred to serum-free medium (2 hours, control) and stimulated with CARTp (2 nM). (B) Co-transfection with A-CREB (1 μg DNA per well) inhibited CARTp (2 nM, 16 hours) stimulation of 3.45 kb CART-Luc, and CARTp only weakly stimulated expression of a Cre-deletion mutant of CART-Luc (ΔCre-CART-Luc). (C) CARTp (2 nM, 2 hours) stimulated nuclear translocation of EGR1. (D) Mutation of a putative EGR1 binding site in CART-Luc (ΔEGR1-CART-Luc) reduced responses to CARTp and so too did pretreatment with EGR1 siRNA. (E) CARTp (2 nM, 16 h) stimulated expression of 3.034 bp Y2R-Luc and co-transfection with A-CREB inhibited this. (F) Pretreatment with EGR1 small interfering RNA reduced CARTp stimulation of Y2R-Luc. Mean ± standard error, n = 6 independent experiments; **P < .01, ***P < .001. Gastroenterology 2010 138, 1479-1490DOI: (10.1053/j.gastro.2009.10.034) Copyright © 2010 AGA Institute Terms and Conditions

Figure 7 Cocaine- and amphetamine-regulated transcript peptide (CARTp) augments the inhibitory action of cholecystokinin (CCK) on food intake after a short but not long fast. (A,B) Cumulative food intake over 0–40 and 0–80 minutes, respectively, in rats fasted for 13 hours and receiving CARTp (2 nmol, intraperitoneal [IP]; ie, “CART priming”) or saline followed 2 hours later by CCK8s (10 nmol, IP) or saline and refeeding; CCK8s inhibited food intake over 0–40 minutes and CARTp had no effect on this but slightly increased food intake on its own. (C,D) Food intake over 0–40 and 0–80 minutes, respectively, in rats fasted for 30 minutes and receiving a priming dose of CARTp or saline followed 2 hours later by CCK8s (or saline) and refeeding; CARTp alone modestly inhibited food intake over 0–40 minutes compared with saline; CCK8s also inhibited food intake over the same period and CARTp enhanced this. (E,F) Food intake over 0–40 and 0–80 minutes, respectively, in rats fasted for 2.5 hours and receiving CARTp or CCK8s (or saline) immediately before refeeding. CARTp alone did not significantly change food intake compared with saline, CCK8s inhibited food intake over 0–40 minutes and CARTp prolonged the action of CCK. n = 6 rats; a,b,c,dDifferent letters denote significant differences between groups (P < .05) ie, a vs b; c vs a or b; d vs a, b, or c. Gastroenterology 2010 138, 1479-1490DOI: (10.1053/j.gastro.2009.10.034) Copyright © 2010 AGA Institute Terms and Conditions